ReviewFrontiers in physiology2021

Potential Mechanisms of SGLT2 Inhibitors for the Treatment of Heart Failure With Preserved Ejection Fraction.

Steffen Pabel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.